980 related articles for article (PubMed ID: 26914546)
1. Factors associated with buprenorphine versus methadone use in pregnancy.
Krans EE; Bogen D; Richardson G; Park SY; Dunn SL; Day N
Subst Abus; 2016; 37(4):550-557. PubMed ID: 26914546
[TBL] [Abstract][Full Text] [Related]
2. Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study.
Meyer MC; Johnston AM; Crocker AM; Heil SH
J Addict Med; 2015; 9(2):81-6. PubMed ID: 25622120
[TBL] [Abstract][Full Text] [Related]
3. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
Johnson S; Martin PR
Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626
[TBL] [Abstract][Full Text] [Related]
4. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
[TBL] [Abstract][Full Text] [Related]
5. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
[TBL] [Abstract][Full Text] [Related]
6. Methadone versus buprenorphine for the treatment of opioid abuse in pregnancy: science and stigma.
Holbrook AM
Am J Drug Alcohol Abuse; 2015; 41(5):371-3. PubMed ID: 26154531
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G
Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938
[TBL] [Abstract][Full Text] [Related]
8. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
Nechanská B; Mravčík V; Skurtveit S; Lund IO; Gabrhelík R; Engeland A; Handal M
Addiction; 2018 Jul; 113(7):1286-1294. PubMed ID: 29443414
[TBL] [Abstract][Full Text] [Related]
9. Delayed villous maturation in term placentas exposed to opioid maintenance therapy: a retrospective cohort study.
Serra AE; Lemon LS; Mokhtari NB; Parks WT; Catov JM; Venkataramanan R; Caritis SN
Am J Obstet Gynecol; 2017 Apr; 216(4):418.e1-418.e5. PubMed ID: 28024988
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine and methadone for opioid addiction during pregnancy.
Mozurkewich EL; Rayburn WF
Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
[TBL] [Abstract][Full Text] [Related]
11. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
[TBL] [Abstract][Full Text] [Related]
12. A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.
Fingerhood MI; King VL; Brooner RK; Rastegar DA
Subst Abus; 2014; 35(2):122-6. PubMed ID: 24821346
[TBL] [Abstract][Full Text] [Related]
13. The Pregnancy Recovery Center: A women-centered treatment program for pregnant and postpartum women with opioid use disorder.
Krans EE; Bobby S; England M; Gedekoh RH; Chang JC; Maguire B; Genday P; English DH
Addict Behav; 2018 Nov; 86():124-129. PubMed ID: 29884421
[TBL] [Abstract][Full Text] [Related]
14. Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.
Klaman SL; Isaacs K; Leopold A; Perpich J; Hayashi S; Vender J; Campopiano M; Jones HE
J Addict Med; 2017; 11(3):178-190. PubMed ID: 28406856
[TBL] [Abstract][Full Text] [Related]
15. Methadone and buprenorphine for the management of opioid dependence in pregnancy.
Jones HE; Finnegan LP; Kaltenbach K
Drugs; 2012 Apr; 72(6):747-57. PubMed ID: 22512363
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of collaborative care treatment of opioid use disorders with buprenorphine during pregnancy.
Mittal L; Suzuki J
Subst Abus; 2017; 38(3):261-264. PubMed ID: 26672650
[TBL] [Abstract][Full Text] [Related]
17. Utilization of buprenorphine and methadone among opioid users who inject drugs.
Tsui JI; Burt R; Thiede H; Glick SN
Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of buprenorphine vs. methadone for pregnant people with opioid use disorder.
Robin AM; Hersh AR; John C; Caughey AB
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):4918-4926. PubMed ID: 33455473
[TBL] [Abstract][Full Text] [Related]
19. Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails.
Sufrin C; Kramer CT; Terplan M; Fiscella K; Olson S; Voegtline K; Latkin C
JAMA Netw Open; 2022 Jan; 5(1):e2144369. PubMed ID: 35050354
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.
Lacroix I; Berrebi A; Garipuy D; Schmitt L; Hammou Y; Chaumerliac C; Lapeyre-Mestre M; Montastruc JL; Damase-Michel C
Eur J Clin Pharmacol; 2011 Oct; 67(10):1053-9. PubMed ID: 21538146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
